The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

Blocking proteins that cause cancer cells to mutate and resist treatment could significantly improve outcomes for some ...

Discrepancies between patients' experiences and friends' lives can strain relationships, highlighting the need for ...

An experimental Boehringer Ingelheim drug achieved “unprecedented” benefits in patients with an advanced form of lung cancer ...

How one man, along with his care team, turned an all-consuming cancer diagnosis into a management strategy with inspiration ...

Raymond Osarogiagbon, MD, highlights the potential benefits of increasing screening rates for patients diagnosed with lung cancer and the broader US health care system.

The ‘cell of origin’ of the second most common lung cancer and the way that it becomes dominant in the lung have been ...

A new artificial intelligence (AI) tool could soon help general practitioners (GPs) detect lung cancer in patients up to four ...

While Spokane celebrates another Bloomsday, only a handful of people can say they’ve done them all. Jack Tenold is one of ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

The American Lung Association is turning Providence, Rhode Island, turquoise this May 5-11, 2025, to raise awareness about lung cancer, honor those impacted and encourage residents to take action to ...